HTG Molecular Diagnostics, Inc. — Net Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/02f2edee-80b9-4414-82ea-0e7c385b0376/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-21.6M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-010975 |
| FY 2021 | $-17.1M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-012240 |
| FY 2020 | $-20.9M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-015554 |
| FY 2019 | $-19.3M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-012877 |
| FY 2018 | $-16.5M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-006806 |
| FY 2017 | $-19.0M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-006602 |
| FY 2016 | $-26.0M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-005153 |
| FY 2015 | $-21.4M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-015252 |
| FY 2014 | $-14.0M | 2014-01-01 – 2014-12-31 | evidence 0001564590-16-015252 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
HTG Molecular Diagnostics, Inc. — all facts · Revenue · Operating Income